Syflexx is a new generation of injectable visco-supplements for intra-articular use. In Syflexx, in addition to its strong lubricating properties and durability, which are based on studies and an examination of the improvable aspects of existing products in the market, special attention has been paid to the design, formulation, and molecular weight of sodium hyaluronate based on biological characteristics and the mechanism of action, as well as the correlation of each with its effectiveness. Syflexx has various sub-brands in which elements such as steroids and biological stimulants are used in combination.
Intra-articular visco-supplement
Syflexx® M
Syflexx M, due to its unique formulation, not only possesses lubricating properties and prevents joint surface wear but also has the highest adhesion to cell surface receptors. This adhesion stimulates fibroblasts biologically, leading to increased production of hyaluronans, collagen, and elastin, potentially contributing to the reconstruction of damaged joints. Additionally, its anti-inflammatory properties prevent the production of pro-inflammatory mediators, thereby reducing pain.
Syflexx H, owing to its specific formulation, contains the most effective viscosity and volume from high molecular weight sodium hyaluronate (HMW). This results in significantly enhanced lubricating properties, providing comprehensive joint surface coverage. With a prolonged treatment duration, it prevents joint surface wear and damage to the cartilage. This not only prevents progressive inflammation but also restores the joint's range of motion.
Syflexx B is a new generation of injectable intra-articular visco-supplements designed and manufactured in a modified-release format. In addition to creating the highest duration of lubricating properties, this product stimulates biological activity and facilitates the reconstruction of damaged joints through the controlled release of linear sodium hyaluronate with medium molecular weight (MMW).
